Smith Group Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q4 | – | Sell |
-967
| Closed | -$1.45M | – | 449 |
|
|
2014
Q3 | $1.45M | Sell |
967
-4
| -0.4% | -$6K | 0.05% | 165 |
|
|
2014
Q2 | $1.33M | Sell |
971
-45
| -4% | -$61.6K | 0.05% | 170 |
|
|
2014
Q1 | $1.41M | Sell |
1,016
-6
| -0.6% | -$8.33K | 0.05% | 170 |
|
|
2013
Q4 | $1.02M | Sell |
1,022
-5
| -0.5% | -$4.98K | 0.04% | 177 |
|
|
2013
Q3 | $1.07M | Sell |
1,027
-107
| -9% | -$111K | 0.04% | 176 |
|
|
2013
Q2 | $1.23M | Buy |
+1,134
| New | +$1.23M | 0.05% | 176 |
|